Sujin Kim
Cheonan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
RAF1 extrachromosomal DNA amplification confers acquired erlotinib resistance in a non-small cell lung cancer cell model.
Journal: Signal transduction and targeted therapy
Published: November 17, 2025
Functional loss of ERBB receptor feedback inhibitor 1 (MIG6) promotes glioblastoma tumorigenesis by aberrant activation of epidermal growth factor receptor (EGFR).
Journal: Molecular oncology
Published: December 05, 2023
Colorectal adenocarcinoma-derived EGFR mutants are oncogenic and sensitive to EGFR-targeted monoclonal antibodies, cetuximab and panitumumab.
Journal: International journal of cancer
Published: December 23, 2018
Early emergence of de novo EGFR T790M gatekeeper mutations during erlotinib treatment in PC9 non-small cell lung cancer cells.
Journal: Biochemical and biophysical research communications
Published: June 01, 2018
Autophosphorylation of the carboxyl-terminal domain is not required for oncogenic transformation by lung-cancer derived EGFR mutants.
Journal: International journal of cancer
Published: July 28, 2017
Identification of Rbd2 as a candidate protease for sterol regulatory element binding protein (SREBP) cleavage in fission yeast.
Journal: Biochemical and biophysical research communications
Published: October 28, 2015
A high-dimensional, deep-sequencing study of lung adenocarcinoma in female never-smokers.
Journal: PloS one
Published: October 04, 2012
Discovery of ALK-PTPN3 gene fusion from human non-small cell lung carcinoma cell line using next generation RNA sequencing.
Journal: Genes, chromosomes & cancer
Published: September 26, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026